Definitive Contract 75A50120C00014
- Not listed
- The Department of Health and Human Services' National Institutes of Health Office of Logistics and Acquisition Operations awarded a $16.5 million definitive contract to Qiagen, LLC for liquid handlers and extractors for coronavirus disease 2019 testing. As the prime contractor, Qiagen will provide the requested products and services to support the NIH's COVID-19 response efforts. The firm fixed price contract runs from August 2020 through December 2021 and will be performed by Qiagen at its...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $55,000.00 firm fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. This contract has a completion date of May 21, 2024. Qiagen is a foreign-owned, for-profit manufacturer that has provided a range of products and services to support federal...
- This firm-fixed price purchase order was awarded by the U.S. Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, to provide laboratory supplies, testing components, and other products to support biosurveillance and COVID-19 testing efforts. The contract has a ceiling value of $165,918.73 and a completion date of March 12, 2018. It does not utilize any set-aside designations. Qiagen Beverly has received similar prime contracts from HHS...
- This federal contract award is for $116,467.47 to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The contract is for "CORONAVIRUS LAB SUPPLIES" and was awarded on February 28, 2020 by the Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh. The contract is a Firm Fixed Price Purchase Order with a completion date of March 4, 2020. Qiagen is a foreign-owned, for-profit manufacturer that...
- This is a $13,445.60 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract is for the delivery of COVID ELISA kits with a performance period running through August 6, 2024. Qiagen is a manufacturer of a wide range of molecular diagnostics, testing, and bioinformatics products that have...
- This is a $148,157.70 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for other unspecified functions and does not have a set-aside designation. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under...
- This $158,946.49 firm-fixed price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is for the provision of laboratory supplies, which are likely to support HHS's biosurveillance and COVID-19 testing efforts, such as the BioWatch program operated by HHS. Qiagen Beverly has received several previous awards from HHS and the Department of the Air Force to supply...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...
- This is a firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the parent company Qiagen N.V. The contract, valued at $165,155.23, is for the supply of laboratory supplies to support biosurveillance and COVID-19 testing efforts. Qiagen Beverly primarily provides products to the BioWatch program, a nationwide biosurveillance system operated by HHS to detect the intentional release of biological agents. The company has...
- This firm-fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $124,775.68 contract is for the provision of lab instruments and is associated with the national interest action for the Coronavirus COVID-19 pandemic response. Qiagen has extensive experience as both a prime contractor and subcontractor providing a range of products and...
This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Qiagen, LLC is valued at approximately $598,000. Under the contract, Qiagen will perform research and development of the QIAstat-DX Respiratory SARS-CoV-2 Panel to aid in the mitigation of long-term effects of respiratory distress, as requested under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Work will be conducted at Qiagen's Germantown, Maryland location through July 2020. The contract has a firm fixed price structure. No subcontractors or set aside designations were indicated. This award supports the Office of the Assistant Secretary for Preparedness and Response's goal of developing technologies and medical countermeasures to combat public health emergencies such as the COVID-19 pandemic.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $598.2k | 3/12/20 |